Hints and tips:
...The Federal Reserve is set to raise interest rates by 0.75 points for the fourth time in a row, and Pfizer raised its sales forecast for its Covid-19 vaccine by $2bn to $34bn on Tuesday....
...“Thanks to their hard work, we achieved a vaccine in record time and currently have multiple vaccines available — enough to reach every corner of the globe,” said John Murphy, chief policy officer at Bio...
...Rivals AstraZeneca, Johnson & Johnson, Russia’s Sputnik V and new entrants such as Novavax make up the remainder of the market, which is forecast to double in value to $124bn next year....
...The AU will pay $6.75 a dose for the BioNTech/Pfizer vaccine and $10 for Johnson & Johnson’s, a single-dose product....
...Additional reporting by Hannah Murphy...
...After such strong reads from the first two releases (three if we count Russia’s Sputnik V), the disappointing AZN figures were perhaps bound to prompt downward pressure on the company’s shares....
...In August, Russia became the first country to approve a Covid-19 vaccine — named Sputnik V — for civilian use, but western experts cast doubt on its efficacy and safety....
...Automation an automatic choiceJapan Inc has found a new purpose for automation: business continuity in the uncertain era of Covid-19....
...The latter is based on the open-source Risc-V architecture....
...Hannah Murphy 17....
...behind hit Fox shows such as The People v OJ Simpson and Glee....
...Murphy Oil was down 3.3 per cent to $29.07, Noble Energy fell 1.5 per cent to $35.57 and Southwestern Energy declined 1.8 per cent to $13.47....
...Shares in Marathon Oil rose 2.7 per cent to $14.25, Chesapeake Energy advanced 2.5 per cent to $5.01 and Murphy Oil gained 2.4 per cent to $28.48....
...Mr Spiegel and his co-founder Bobby Murphy, rejected the overture, a move that has paid off for them: after this week’s IPO their stakes are worth more than $4bn each....
...Merck, the drug manufacturer, dropped 2.8 per cent to $55.89, Pfizer fell 1.5 per cent to $34.22 and Johnson & Johnson lost 1 per cent to $115.48....
...Shares in Pfizer fell 1.8 per cent to $33.64 after the pharmaceuticals group said it would not pursue plans to split into two companies....
...Related links: Pfizer, Allergan to combine in $160bn deal – FT Pfizer looks to bulk up in era of slimming down – FT Ian Read: the pragmatist out to transform the drugs industry – FT, 2014...
...Pfizer fell 1.9 per cent to $34.77. Murphy Oil was another strong performer....
...Additional reporting by Barney Jopson and Megan Murphy...
...reports, such as this one from Sky’s Mark Kleinman… … Sky News has learnt that fund managers at BlackRock, which owns approximately 8% of AstraZeneca, have told its directors that they should re-engage with Pfizer...
...Note, importantly, Pfizer didn’t pay The Standard to run the commentary, which was probably offered to other newspapers, including this one....
...Elsewhere on Monday, - AstraZeneca rejects £55 from Pfizer, wanted £59 - Stress test tested - A Taiwanese in Vietnam - California, scorched - Almost systemically important - Serious coinage...
...The possibility of a Pfizer/AstraZeneca deal still has the politicians talking (the chief executives of both were hauled before the UK parliament this week)....
...Richard Murphy, a prominent tax campaigner, said the UK was attracting the headquarters of companies with no real ties to Britain....
International Edition